Evofem Biosciences, Inc. Annual Operating Income (Loss) in USD from 2013 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Evofem Biosciences, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2013 to 2023.
  • Evofem Biosciences, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$1.39M, a 81.1% increase year-over-year.
  • Evofem Biosciences, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$11.2M, a 73.2% increase year-over-year.
  • Evofem Biosciences, Inc. annual Operating Income (Loss) for 2023 was -$17.8M, a 78.8% increase from 2022.
  • Evofem Biosciences, Inc. annual Operating Income (Loss) for 2022 was -$84.1M, a 49.6% increase from 2021.
  • Evofem Biosciences, Inc. annual Operating Income (Loss) for 2021 was -$167M, a 61% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$17.8M +$66.3M +78.8% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-27
2022 -$84.1M +$82.7M +49.6% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-27
2021 -$167M -$63.2M -61% Jan 1, 2021 Dec 31, 2021 10-K 2023-04-27
2020 -$104M -$50.9M -96.5% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-10
2019 -$52.7M +$24.9M +32.1% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-04
2018 -$77.6M -$42M -118% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-12
2017 -$35.7M -$1.04M -3.01% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-01
2016 -$34.6M +$7.41M +17.6% Jan 1, 2016 Dec 31, 2016 8-K/A 2018-04-06
2015 -$42M -$32.5M -338% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-26
2014 -$9.59M +$4.83M +33.5% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-23
2013 -$14.4M Jan 1, 2013 Dec 31, 2013 10-K 2016-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.